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Chronic obstructive pulmonary disease (COPD) is present in 10.1% of the population and is the fourth
leading cause of death in the United States while the prevalence of asthma in adults is 6.7%.1 Patients
presenting to primary care ofﬁces with lower respiratory tract symptoms like dyspnea and wheezing are
often diagnosed with COPD or asthma and started on treatment. There are uncommon conditions like
Mounier-Kuhn syndrome (MKS) that can present with similar symptoms and it is important for the
primary care physician to keep them in mind when evaluating patients. It is important to identify MKS,
as early recognition can lead to better management and prevention of complications. We describe a case
of an older gentleman with recurrent symptoms of shortness of breath and intermittent spells of
productive sputum who was misdiagnosed with COPD for years. Our diagnosis was supported by
a clinical history and conﬁrmed by radiographic evidence.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Chronic obstructive pulmonary disease (COPD) is present in
10.1% of the population and is the fourth leading cause of death in
the United States while the prevalence of asthma in adults is 6.7%.1
Patients presenting to primary care ofﬁces with lower respiratory
tract symptoms like dyspnea and wheezing are often diagnosed
with COPD or asthma and started on treatment. There are
uncommon conditions like Mounier-Kuhn syndrome (MKS) that
can present with similar symptoms and it is important for the
primary care physician to keep them in mind when evaluating
patients. It is important to identify MKS, as early recognition can
lead to better management and prevention of complications. We
describe a case of an older gentleman with recurrent symptoms of
shortness of breath and intermittent spells of productive sputum
who was misdiagnosed with COPD for years. Our diagnosis was
supported by a clinical history and conﬁrmed by radiographic
evidence.2. Case presentation
A 63-year-old African American gentleman presented to our
hospital for evaluation of worsening shortness of breath withh St., Jacksonville, FL 32209,
), abubakr.bajwa@jax.uﬂ.edu
rved.dyspnea and wheezing at rest. He has a history of multiple emer-
gency room visits with shortness of breath. He denied cough,
hemoptysis, fever, chills, chest pain or weight loss. He did not have
a history of smoking, alcohol or illicit drug use. He worked as a bus
driver and had no occupational exposures. Examination revealed
a thin, cachectic man in moderate respiratory distress with
increased work of breathing and accessory muscle use. Initial vital
signs were normal. Auscultation of lungs revealed decreased breath
sounds, and wheeze bilaterally with ronchi. He was alert and
oriented with no other abnormal exam ﬁndings.Fig. 1.
Fig. 2.
Table 1
Diagnostic criteria based on transverse diameters of the trachea and bronchi.
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apical caps and small bilateral pleural effusions. CT scan of the
thorax demonstrated a marked dilatation of the intrathoracic
trachea and both main bronchi. It also revealed diffuse interstitial
lung disease and bronchiectasis most noticeable within the right
upper lobe (Fig. 1 and 2). Work up for causes of interstitial lung
disease such as sarcoidosis, rheumatoid arthritis, other connective
tissue diseases and environmental exposures were negative.
His hospital course was complicated by respiratory failure
requiring intubation and mechanical ventilatory support.Fig. 3. Guideline in maBronchoscopy also conﬁrmed the diagnosis of MKS with normal
cytology and negative cultures including acid fast bacilli. After
successful treatment with intravenous antibiotics the patient was
successfully weaned off inotropes and mechanical ventilation. On
the seventh hospital day he developed worsening respiratory
distress, became hemodynamically unstable and later expired due
to a cardiac arrest.3. Discussion
Tracheobronchomegaly or Mounier-Kuhn Syndrome (MKS) is
a rare disorder that was ﬁrst described by Mounier-Kuhn in 1932.2
MKS is more commonly seen in males in their third or fourth
decade of life. The etiology ofMKS is unclear. Most theories propose
that genetic predispositions coupled with environmental factors
are the likely etiological factors.3 A familial form with possible
recessive inheritance has also been described. MKS is also believed
to be associated with various connective tissue disorders such as
Ehlers-Danlos syndrome, Marfan syndrome, ataxia-telangiectasia,
Bruton-type agammaglobulinemia, ankylosing spondylitis, cutis
laxa, and light chain deposition disease.4–6
Pathophysiology: congenital defects or connective tissue weak-
ness leads to pathological dilation of the trachea and main bronchi.
Membranous tissue between the tracheal cartilages can bulge,
forming tracheal diverticulosis. Patients frequently have mucus
retention secondary to weakened airways and multiple diverticuli
forming pockets of mucus that lead to inefﬁcient cough, further
impeding mucociliary clearance. These compromised airway
protective mechanisms, often result in recurrent pneumonias,
bronchiectasis and ﬁbrosis.7–8
Clinical features: clinical presentation is similar to chronic
obstructive pulmonary diseases (COPD). Patients typically present
with cough and excessive sputum production with or without
hemoptysis as a result of the impeded mucociliary clearance and
multiple mucus collection zones. These symptoms over time, leadnagement of MKS.
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neous pneumothorax may also develop.9,10
Diagnosis: an increased diameter of the trachea on a plain
radiograph should raise suspicion, but CT Imaging is the gold
standard for making this diagnosis using transverse diameters of
the trachea and bronchi. Transverse diameters of the trachea, right
bronchus, left bronchus and measurements exceeding 30 mm,
20 mm, 18 mm, respectively are widely accepted as diagnostic
(Table 1).11,12
Management: proper management of MKS is dependent on an
early diagnosis and treatment according to severity of the disease
(Fig. 3). The disease should be kept in mind while evaluating
patients with COPD or Asthma and while reviewing radiological
data. MKS can be classiﬁed into mild, moderate or severe categories
based on symptomatology. Incidentally diagnosed individuals or
those with mild disease are generally asymptomatic and may
present with upper or lower respiratory infections. These patients
usually require no additional treatment. However, they should be
followed by their primary physicians at least on a yearly basis and
receive routine ﬂu and pneumococcal vaccinations.
Moderate severity of disease is seen in patients who have upper
or lower respiratory infections at frequencies and severity higher
than the general population. These patients typically have more
severe symptomatology which may include hemoptysis, sponta-
neous pneumothorax and respiratory failure. They require aggres-
sive physical therapy and postural drainage techniques to prevent
mucus retention and to aid with clearing of secretions. Infections
should be treated early with appropriate antibiotics. In certain
cases bronchoscopy may be needed to clear occluded bronchial
airways of secretions.
Similar to our patient, advanced cases of MKS have a very poor
prognosis and are usually noted on autopsy. These patients tend to
have severe recalcitrant mucus plugs, tracheal diverticuli and
ﬁbrotic changes which eventually lead to respiratory failure and
their demise. Tracheal stenting has proved beneﬁcial in patients
with multiple tracheal diverticuli.13,14 Since MKS involves diffuse
areas of the airway, surgery on selective parts of the bronchial tree
is very difﬁcult. However a few rare cases of lung transplantation
have been reported in the literature with no proven beneﬁt in
mortality.15–17In spite of its rare occurrence MKS is a condition that is easily
missed by the clinician and can be fatal if early intervention is not
taken. With the advent of CT imaging more patients with MKS is
likely to be identiﬁed and a treatment protocol must be adapted as
suggested above.More studies are required to study the implication
of treatment on morbidity and mortality.References
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